GlassScriptPhysician profile
Jacob B Conditt
NPI 1609490531
$2,226.98
in general payments reported to CMS, 2019-2025
16 companies · $767 in 2025
The $767 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $265 · 2023: $648 · 2024: $548 · 2025: $767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,962.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $406.97 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Alcon Vision LLC | $276.00 | 2022-2025 | Rocklatan, Tryptyr |
| Tarsus Pharmaceuticals, INC. | $202.34 | 2024-2025 | Xdemvy |
| Amgen INC. | $190.63 | 2025 | Tepezza |
| Abbvie INC. | $180.54 | 2023-2025 | Xen Glaucoma Treatment System |
| Thea Pharma INC. | $170.52 | 2023-2025 | Iyuzeh |
| Apellis Pharmaceuticals, INC. | $150.97 | 2023 | Syfovre |
| Horizon Therapeutics Plc | $130.85 | 2022-2023 | Tepezza |
| Coopervision INC. | $118.32 | 2024-2025 | Cvi Contact Lens, Myday Contact Lens |
| Harrow Eye, LLC | $94.54 | 2024-2025 | Vevye |
| Johnson & Johnson Vision Care, INC. | $88.04 | 2022 | |
| Novartis Pharmaceuticals Corporation | $73.20 | 2022-2023 | |
| Glaukos Corporation | $53.90 | 2025 | Istent Infinite |
| Abb Con-Cise Optical Group LLC | $36.34 | 2023 | Contact Lens, Spectacle Lenses |
| Johnson & Johnson Surgical Vision, INC. | $31.40 | 2025 | Tecnis Iol |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $22.42 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Conditt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.